An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations
Clinical trial NCT06913725 · RECRUITING
Trial details
- NCT number
- NCT06913725
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2026-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.